Straits Times Index
3,367.90 +29.33 (+0.88%) S&P 500
5,475.89 +0.80 (+0.01%) Dow
39,143.48 -26.04 (-0.07%) Nasdaq
17,894.56 +15.27 (+0.09%) Bitcoin USD
62,265.62 -489.37 (-0.78%) CMC Crypto 200
1,332.55 -11.96 (-0.89%)
EDIT Feb 2025 5.000 call
| Previous close | 1.5000 |
| Open | 1.4000 |
| Bid | 0.9500 |
| Ask | 1.5000 |
| Strike | 5.00 |
| Expiry date | 2025-02-21 |
| Day's range | 1.4000 - 1.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
Insider MonkeyIs Editas Medicine, Inc. (EDIT) One of the Best Biotech Penny Stocks to Buy Now?
We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we are going to take a look at where Editas Medicine, Inc. (NASDAQ:EDIT) stands against the other biotech penny stocks. Biotech Stocks in 2024: Growth Prospects, Key Players, and Investment Opportunities In 2024, the healthcare industry has […]
- Insider Monkey
What Makes Editas Medicine, Inc. (EDIT) One of the Best Small-Cap Stocks with Highest Upside Potential?
We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this article, we are going to take a look at where Editas Medicine, Inc. (NASDAQ:EDIT) stands against the other small-cap stocks. Small-cap stocks are companies with a market capitalization of somewhere between $250 million and $2 billion. They are usually […]
ZacksEditas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Editas (EDIT) reports positive new safety and efficacy data from the RUBY and EdiTHAL studies evaluating its investigational gene therapy, reni-cel, for SCD and TDT, respectively.
